Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
June 18, 2020 12:16 PM 7 min read

Stanley Brothers Take Two: When First Swing Equals Grand Slam, What Arises With A Next At Bat?

by Michael Miller Benzinga Contributor
Follow
CWBHF Logo
CWBHFCharlottes Web Holdings Inc
$0.7200-1.37%
Overview

See also: From Sharing To Selfish: Can The Cannabis Community's Ethos Survive COVID-19?

In 2013, the world was introduced to the journey of the Stanley Brother’s mission in a big way, when CNN’s Dr. Sanjay Gupta featured the life-changing reduction in Charlotte’s seizures using a Stanley Brothers whole plant CBD tincture. This process ultimately forced a challenge to public perceptions, many of which were misguided or simply wrong. It also served as a catalyst to change laws, ignite further research, and accelerate the global CBD industry.

Despite the entering of cannabis into the US culture mainstream the last few years, with dominoes of state legalization continuing to fall, daily cannabis use still can’t completely shake its long term historical stigma, often coming with skepticism and eye rolls. To address this, the Stanley Brothers developed a product promise to include consistency, quality and dosage efficacy.

See also: Prohibition Déjà Vu: Cannabis And COVID-19

Courtesy photo.

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Noticias sobre cannabis en Español en El Planteo.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisNewsPenny StocksExclusivesMarkets

As our nation gets prepared for its ‘new normal’, whatever that really means, consumers will likely be stretching their dollars as never before. Consumers will likely seek cost effective,  alternative methods for mind, body and spiritual relief, one of which could be CBD and the seemingly endless supply of products in which it is an ingredient. Stocks are thriving despite the pandemic and international protests, which provides a glimmer of greatly needed economic hope.

A recent research report by Data Bridge Market Research projects the CBD market to grow at the extraordinary rate of nearly 32% between 2020 and 2027. With near consensus on the benefits of whole plant medicine, it’s a good time to reconsider THC as a ‘health’ NOT a ‘high component’. After having spent some time with Joel Stanley in London at the Centre for Medical Cannabis in London during EuroCannabis week last year, I looked forward to following up after hearing rumors that the Stanley Brothers would be returning to their canna-roots with the launch of a new full-spectrum line of low-dose THC products under the brand name, ReCreate.

The new venture’s products target functional wellness with the objective of promoting “repeatability”: consistent results with each use, anytime, anyplace, a la a Starbucks latte which tastes the same no matter where sipped. The line is formulated with CBD, THC and botanicals. “Having started our journey in medical marijuana, the launch of ReCreate feels like a homecoming and is the culmination of everything we’ve learned from our early days in medical marijuana to Charlotte’s Web”, Jesse Stanley, ReCreate’s Co-Founder and CEO told me. The Stanley’s are committed to rigorous cannabinoid research and development to reimagine a next generation THC experience in the form of daily, low-dose consumables.

For the few who are not familiar with the Stanley Brothers, or those who have been hiding under a rock the last few years, let’s hit a quick rewind. Their initial mission to serve the community through wellness came to fruition in 2009.  From their Colorado headquarters, they grew and sold medical marijuana for cancer and other patients. With the nascent industry predominantly THC focused, the Stanley Brothers focused on alternative research to leverage the potential health benefits of CBD and other cannabis compounds.

This process resulted in the discovery of optimal genetics of wild hemp that grew across America. At that time, with most consumers wanting a high THC strain, breeders focused in the psychoactive and more profitable arena. As THC and CBD are controlled by the same genetic code during development, the quest for ever more percentages of THC caused at first, substantial reductions in CBD and other cannabinoid components from the plant, followed by CBD being nearly bred out altogether.  Their genetic discoveries would later become the basis of Stanley Brothers hemp-based CBD products, named after a couragous girl, named Charlotte Figi who struggled and suffered with catastrophic epilepsy for years and tragically passed away earlier this year.

“Charlotte was the heartbeat of our passion; what began as her story, became the shared story of hundreds of thousands, and the inspiration for millions in a journey for  betterment,” says Stanley. With a business policy based on a foundation of care and compassion, the Brothers provided products to thousands of needy patients, many of whom were children, through their non-profit, Realm of Caring, which empowers individuals, medical professionals, and the community through research-based education on hemp, CBD, medical marijuana, and THC. 

As demand for their CBD-based tinctures expanded and production neared capacity, the Brothers turned their mission into a business; in 2014, Charlotte’s Web, as a company was born whose focus was to revolutionize how plants (hemp and its byproducts specifically) can provide relief. They created hemp-based wellness company, Charlotte’s Web Holdings Inc. (OTC:CWBHF). With growing global demand, the Brothers made the decision that the fastest way to raise capital and scale their business was to file for a public offering which it completed in August of 2018 with total gross proceeds of C$115,115,000 (USD $87,598,872)”. Still active, the brothers doubled-down on plant exploration with access to resources for genetic data research and development.

The repeatable effects are established through meticulous operating procedures in compliance with state-to-state regulations and a distinct point of differentiation for ReCreate suggests Stanley, “Consistency leads to trust; trust leads to repeatability, and repeatability enables desired wellness levels. The rules are being rewritten and our culture is at the dawn of the new era of personalized therapies. We’ve been inspired to recreate the 1.0 version of cannabinoid treatments by looking at the plant as a whole”. Stanley added that  “Our family’s relationship with cannabis and plant research has been long-term; we’ve made mistakes on our journey and believe we have learned from them. ReCreate is an aggregated culmination of knowledge since our very humble beginnings. Its our name on the package transparently, so consumers can have a degree trust they may not have in other products.”

The evolution from CBD to THC reflects the Stanley Brother’s research allowing them to better understand the full-spectrum benefits and potential of the plant. With ReCreate, the brothers desired a daily wellness supplement.  In furtherance of their altruistic endeavors and desire to give back to their community, ReCreate will launch with a COVID-19 Relief program that provides $100,000 worth of wholesale products for those that have been financially impacted. “There’s no single way to deal with life’s uncertainties” says Stanley. “One person’s anxiety is not another’s. ReCreate by any means, is not a cure-all but, if we can make a small  difference, we’ll do so by helping those that can not afford needed therapies. The COVID Relief program is currently offered at select dispensaries in both Colorado and California.

ReCreate addresses specific wellness needs with products such as Focus, Relax, Relief & Sleep as an every day tincture. Stanley told me that their core demographic is both the “awakened consumer”, educated in plant-based therapies and holistic health, and for novice consumers considering or reconsidering use. “Why botanicals?” I asked Stanley who said, “Cannabis is so complex; with over 500 distinct compounds, CBD and THC are just two, leaving one to wonder about the potential for the other 498 and the almost unending amount of combinations”.

Botanicals have been used since antiquity in Eastern cultures, especially in the Ayurvedic traditions of India which prioritize natural medicines. ReCreate infuses valerian root, turmeric, and others including Lions Mane, Chaga and Ashwagandha mushrooms (‘plant adaptogens,’ a select group of herbs and mushrooms that support the body's natural ability to deal with stress). Increasing consumer awareness for botanical therapies has made them a common sight on grocery store shelves. In dispensaries, products are crafted to harmonize optimal cannabinoid ratios to adapt to restore balance and provide healing properties.

The current product line is made up of two of my favorite things: chocolates and tinctures. Tinctures are available in 15 and 30 ML and THC dosage ranges from 2.5mg - 10mg with CBD /THC rations ranging from 10:1 to 2:1 (CBD:THC).  Gummies and other products are anticipated to be released later in the year. After product testing hundreds of CBD and CBD/THC products this year alone, I came to the table with low expectations. I was pleasantly surprised, first by the taste which was clean without the typical harsh bitterness and its pleasing liquid chocolate finish. Each of the products performed well, ranging from a slight body buzz for focus and creativity to  head-to-toe relaxation for stress, anxiety and sleep. “I believe we’ll see a shift from ‘what will this do TO me?’, to ‘what can this do FOR me? When you choose ReCreate, you’re choosing it for health, not high.” Kudos to the Stanley Brothers for a killer second act.

CWBHF Logo
CWBHFCharlottes Web Holdings Inc
$0.7200-1.37%
Overview
Comments
Loading...